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Abstract
Background and purpose Simultaneous dissection of three or four cervical arteries rarely occurs. As a result, limited infor-
mation is available on clinical characteristics, underlying causes, treatment, and outcome of these patients.
Methods We performed a systematic review of individual patient data on triple and quadruple cervical artery dissection 
(CeAD). We included all cases for whom, at minimum, data on age, sex and affected cervical arteries were available.
Results Out of 1396 publications identified in the initial search, 52 were included, with data available on 96 patients. Mean 
age was 42 years and 66% were women. 63% had triple CeAD. The most common manifestations were headache (69%), 
neck pain (44%), motor deficit (36%), and Horner syndrome (34%). 57% had an ischemic stroke, in the majority of these 
patients the stroke was confined to the vascular territory of a single artery. 83% were managed medically (antiplatelets or 
anticoagulants) and 11% underwent endovascular treatment. An underlying disease or triggering event was identified in 71%, 
most commonly trauma (35%, cervical manipulative therapy in 13%), infection (18%), fibromuscular dysplasia (16%), and 
hereditary connective tissue disorder (8%). In-hospital mortality was 1%. 80% of patients had a good functional outcome 
(mRS 0–1) at follow-up. Two recurrences (3%) were reported.
Conclusions Triple or quadruple CeAD mostly affected young women, and underlying disease or triggering event could be 
identified in more than two-thirds of patients. Less than two-thirds of triple or quadruple CeAD patients suffered ischemic 
stroke. Most patients were managed medically and the majority had a favorable outcome.
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Introduction
Cervical artery dissection (CeAD) accounts for approxi-
mately 20% of strokes in patients less than 45 years of 
age [1]. In most cases, dissection occurs in a single artery. 
Simultaneous dissection of three or four cervical arteries 
is a rare occurrence. About 2–4% of all CeAD comprise of 
triple or quadruple dissections, compared to 13–23% double 
and 73–85% single dissections [2–5]. There are a few case 
reports or case series on triple or quadruple dissections and 
large cohort studies generally only report in terms of sin-
gle or multiple dissections, without distinguishing patients 
within the latter group. Because of the paucity of data on 
triple and quadruple CeAD, little is known about the clinical 
manifestations, underlying causes, treatment, and outcome 
of these patients. The aim of the current study was to per-
form a systematic review of individual patient data on triple 
and quadruple CeAD.
Patients and methods
We performed a systematic review according to Preferred 
Reporting Items for Systematic Reviews and Meta-Analy-
ses of Individual Patient Data (PRISMA-IPD) guidelines 
[6]. We searched Pubmed and Excerpta Medica Database 
(EMBASE) (from inception to April 17, 2018) using a 
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predefined search strategy including the terms multiple, tri-
ple, or quadruple cervical artery dissection (Online Resource 
Fig. I). Full-length articles and conference abstracts were 
reviewed. The primary search was performed indepen-
dently by two authors (V.G. and J.M.C). Full-length articles 
of potentially relevant studies were reviewed by one of the 
authors (V.G). Triple or quadruple CeAD was considered 
simultaneous if the dissections were simultaneously present 
on baseline imaging of the cervical arteries, or if on baseline 
imaging an initial dissection was visible and additional dis-
sections were diagnosed within 30 days. For inclusion in the 
study, triple or quadruple CeAD had to have been diagnosed 
by MRI, MRA, CT-angiography (CTA), catheter angiogra-
phy, or autopsy, on the basis of at least one of the following 
criteria: (1) double lumen; (2) mural hematoma; (3) tapering 
occlusion or long tapering stenosis. We included all cases 
for which at minimum the following individual patient data 
were available: age, sex, and affected cervical arteries. If this 
information could not be extracted from the article, the cor-
responding author was contacted to provide relevant data on 
five separate occasions. Articles written in languages other 
than English, French, German, Spanish, Italian or Dutch 
were included if they had an English abstract that contained 
sufficient data. Fibromuscular dysplasia (FMD) diagnosis 
had to be based on histological examination or multifo-
cal arterial stenosis with ‘string-of-beads’ appearance on 
catheter angiography, MRA, or CTA. Hereditary connec-
tive tissue disorders had to be confirmed by genetic testing. 
Trauma was defined as any reported mechanical triggering 
event with impact on the head or neck, including major or 
minor trauma (e.g. motor vehicle accident, fall, notable 
head/neck movements, sports activities, cervical manipula-
tive therapy). Medical management was defined as treatment 
with antiplatelets or anticoagulants, without surgery or endo-
vascular intervention. As main clinical outcome, we used the 
modified Rankin Scale (mRS). If outcome was only reported 
descriptively, we attempted to construct a mRS score from 
this information (e.g. ‘full recovery’—mRS 0). Recanaliza-
tion at follow-up imaging was defined as improved arterial 
flow (partial or complete recanalization) in all affected arter-
ies. If one or more arteries remained occluded, recanaliza-
tion was reported as absent. Data were summarized using 
descriptive statistics (medians, means, SDs, frequencies), 
using IBM SPSS Statistics V.23 (IBM). We also compared 
key findings of the current study to available data of patients 
with double and single CeAD from the Cervical Artery Dis-
section and Ischemic Stroke Patients (CADISP) study, one 
of the largest multicenter cohort studies in the literature 
[3]. Data of patients with triple/quadruple vs single CeAD 
were analyzed using the  OpenEpi® software program (Open 
Source Epidemiologic Statistics for Public Health V3.01). 
For comparison of continuous data, we used a two-sided 
independent t test and for a comparison of proportions, we 
used a chi-square test or Fisher’s exact test, whichever was 
appropriate.
Results
A flowchart of study selection is provided in Online 
Resource Fig. I. Of the 1396 manuscripts identified in the 
initial search, 168 were selected for full-length review. 
Of these, 52 studies were included, containing individual 
patient data of 96 patients. Study characteristics are depicted 
in Online Resource Table I. The studies were published 
between 1977 and 2017. 41 studies were case reports or 
case series. Clinical characteristics are reported in Table 1. 
8% of patients presented with only headache or neck pain 
without additional neurological symptoms.
MRI was performed in 83% of patients, MRA in 67%, 
catheter angiography in 59%, CTA in 23%, and autopsy in 
1%. In 88/96 (92%) patients, triple or quadruple CeAD were 
simultaneously identified on baseline imaging. In 8/96 (12%) 
patients, an initial dissection was visible on baseline imag-
ing, followed by diagnosis of additional dissections within a 
median of 4 days (IQR 1–17). Data on radiological findings, 
treatment and outcome are presented in Table 2. 63% had 
triple and 37% had quadruple CeAD. 57% of patients had 
an ischemic stroke at presentation or during hospitalization. 
Table 1  Clinical characteristics
CeAD cervical artery dissection
a Calculated from data of 96 patients
b Calculated from data of 46 patients
n/N (%)
Demographics
 Mean age, year (SD)a 42 (9)
 Sex (% women) 63/96 (66%)
Medical history
 Current or past smoking 20/72 (28%)
 Hypertension 16/72 (22%)
 Migraine 25/72 (35%)
 Diabetes 4/72 (6%)
 Hypercholesterolemia 12/72 (17%)
 Oral contraceptive use (women) 6/63 (14%)
Clinical characteristics
 Headache 63/92 (69%)
 Neck pain 40/92 (44%)
 Headache or neck pain as the only symptom 8/96 (8%)
 Motor deficit 26/72 (36%)
 Horner syndrome 31/92 (34%)
 TIA 17/92 (19%)
 Median duration symptom onset, diagnosis CeAD 
(range)b
4 days (0–31)
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Information on the duration of antithrombotic treatment was 
available for 64% of the patients who were managed medi-
cally. 4% were treated for less than 6 months, 58% for (at 
least) 6 months, 36% long term, but without further speci-
fication, and 2% indefinitely. 11% underwent endovascular 
stent placement. The median time between symptom onset 
and the endovascular procedure was 3 days (range 1–120). In 
half of these cases, the reason for the intervention was neuro-
logic deterioration despite medical management. One patient 
(1%) died during hospitalization as a result of hemorrhagic 
transformation of a cerebral infarct. This patient was a 
49-year-old man with fibromuscular dysplasia and quadru-
ple CeAD which had occurred during skiing. Two recurrent 
CeADs were reported.
Information on underlying causes of CeAD was avail-
able for 94/96 patients and in 67 (71%) an underlying dis-
ease or triggering event could be identified (Table 3). 12 
patients (eight women) were diagnosed with FMD. Three 
patients (two women) had Ehlers–Danlos type IV and one 
woman had osteogenesis imperfecta type I. Triggering 
events included infection (n = 16), trauma (n = 32, cervical 
manipulative therapy in 12/32 patients), recent childbirth 
(n = 5), and other (n = 17).
An overview of key findings of the current study com-
pared to available data of patients with double and single 
CeAD from the Cervical Artery Dissection and Ischemic 
Table 2  Radiological findings, treatment, and outcome
CeAD cervical artery dissection, ICA internal carotid artery, mRS 
modified Rankin Scale, VA vertebral artery
a Hemorrhagic transformation of a cerebral infarct in 4 patients, 
related to traumatic injuries in 1 patient
b 4 patients received both concurrently; 22 sequentially; for 2 the order 
of administration was not provided, respectively
c In 55% a documented mRS was available, in 45% it was imputed. 
Median time to last clinical follow-up (range): 4 months (0–98). Out-
come (mRS) in patients with ischemic stroke was: 0, 35%; 1, 33%; 2, 
13%; 3, 8%; 4, 10%; 5, 0%; 6; 3%. Outcome (mRS) in patients with-
out ischemic stroke was: 0, 72%; 1, 22%; 2, 3%; 3, 3%; 4–6, 0%
d Last imaging follow-up: <3 months in 5 patients; 3–6 months in 16; 
6–12 months in 5; >12 months in 3; and not specified for 2
n/N (%)
Radiological findings
 Triple CeAD 60/96 (63%)
 2xICA and 1xVA 40/60 (67%)
  Ischemic stroke 52/91 (57%)
 1 cervical artery vascular territory 23/36 (64%)
 Subarachnoid hemorrhage 6/90 (7%)
 Intracerebral  hemorrhagea 5/90 (6%)
Treatment
 Medical management 70/84 (83%)
 Antiplatelets 17/84 (20%)
 Anticoagulants 23/84 (27%)
 Antiplatelets and  anticoagulantsb 28/84 (33%)
 Unspecified 2/84 (2%)
 Endovascular stent placement 9/84 (11%)
 Surgery 1/84 (1%)
 None of the above 4/84 (5%)
mRS score at last clinical follow-upc
 0 39/74 (53%)
 1 20/74 (27%)
 2 6/74 (8%)
 3 4/74 (5%)
 4 4/74 (5%)
 5 0/74 (0%)
 6 1/74 (1%)
Recurrence of CeAD 2/80 (3%)
Recanalizationd 28/31 (90%)
Table 3  Underlying disease and/or triggering events
In 9 patients both an underlying disease and a triggering event were 
identified. In 9 other patients more than 1 triggering event was identi-
fied
a 8 women, 4 men
b Ehlers–Danlos type IV in 3 patients (2 women) and osteogenesis 
imperfecta type I in 1 (woman)
c Respiratory in 10, gastro-intestinal in 2, sinusitis in 2, hepatitis C 
in 1, and 1 patient had elevated inflammatory parameters without an 
identified focus
d Motor vehicle accident in 8, fall from skiing in 1, fall from a horse 
in 1, fall in 1; heavy load carrying in 1, head extension in 2, and 
other head movements in 2; cervical manipulative therapy in 12; 
sports activities in 6: skiing in 1, scuba diving in 1, river rafting in 1, 
cycling in 1, yoga in 1, heavy weight lifting in 1
e Cesarean section in 4 and vaginal delivery in 1 woman
f Other factors that were considered triggering events by authors 
of included publications: recent head/neck surgery in 1, head/neck 
surgery in distant medical history in 9, reversible vasoconstric-
tion syndrome in 3, chronic ergotism in 1, alemtuzumab therapy in 
1, iatrogenic vessel wall damage during angiography in 1, positive 
thrombophilic markers in 1 patient
g Calculated from data of 27 patients. The nine patients with head/
neck surgery in distant medical history were excluded (median dura-
tion risk factor, symptom onset was 19 years; range 9–50 year)
n/N (%)
Underlying disease and or triggering event identified 67/94 (71%)
 Fibromuscular  dysplasiaa 12/74 (16%)
 Hereditary connective tissue  disorderb 4/50 (8%)
 Recent  infectionc 16/90 (18%)
 Traumad 32/90 (35%)
 Cervical manipulative therapy 12/90 (13%)
 Recent childbirth (women)e 5/59 (7%)
 Otherf 17/94 (18%)
None identified 27/94 (29%)
Unknown 2/96 (2%)
Median duration risk factor, symptom onset (range)g 5 days (0–22)
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Stroke Patients (CADISP) study [3] is provided in Online 
Resource Table II. Patients with triple/quadruple CeAD 
were more often female (66% vs 42%, p < 0.001), more 
often had underlying fibromuscular dysplasia (16% vs 4%, 
p < 0.001) or a hereditary connective tissue disorder (8% vs 
0.4%, p < 0.001) compared to patients with single CeAD. 
There was no difference in clinical outcome (mRS 0–2 88% 
vs. 88%, p = 0.951) or frequency of recurrent CeAD (3% vs 
2%, p = 1.000).
Discussion
This is the first systematic review on triple and quadruple 
CeAD. Despite the rarity of this condition, we were able 
to collect data from almost 100 patients. In most patients a 
cause or risk factor for CeAD was identified, stressing the 
need for a careful patient history and diagnostic work-up in 
these patients. Most patients with triple or quadruple CeAD 
were managed medically. While CeAD was complicated by a 
stroke or TIA in the majority of patients, in-hospital mortal-
ity was low and clinical outcome was favorable (mRS 0–1) 
in 80% of patients.
Cohort studies of CeAD suggest that an inherited connec-
tive tissue disorder is found in less than 0.5% of patients in 
patients with single CeAD [7] [Online Resource Table II], 
which is considerably lower than the 8% in our systematic 
review. Similarly, FMD was found in only 4% of CADISP 
study patients with a single CeAD [3] [Online Resource 
Table II], compared to 16% in our systematic review. This 
would suggest that patients with triple or quadruple CeAD 
are more likely to have an underlying connective tissue dis-
order. However, these differences may also be a result of 
publication or verification bias, as triple or quadruple CeAD 
likely leads to more thorough ancillary investigation.
There is usually no sex predominance in European popu-
lations for cervical artery dissections. However, in studies 
reporting single and multiple CeAD separately, there does 
seem to be a trend towards higher proportion of women in 
multiple CeAD [3, 5]. The skewed sex ratio (with two-thirds 
of women) we observed may be explained by sex-specific 
risk factors such as FMD, which occurs in women in about 
90% of cases, and recent childbirth.
18% of patients had a recent infection, which is similar 
to the frequency among patients with single CeAD [3, 5] 
(Online Resource Table II). This association may be due 
to mechanical forces such as violent coughing, sneezing or 
vomiting, or due to a transient inflammatory arteriopathy 
[8]. Recent cervical manipulative therapy was another trig-
gering event that was frequently reported. Various controlled 
studies have observed an association between manipulative 
therapy and CeAD, particularly of the vertebral arteries 
[9] and multiple CeAD [3]. Despite the clear association, 
it remains unknown whether there is also a causal rela-
tion, since patients may have sought manipulative therapy 
because of neck pain caused by the dissection. At the very 
least, therapists should inform patients on the possible risk 
of causing CeAD prior to performing manipulative therapy.
Five women had recently given birth. As most of the 
patients in this study were women within child-bearing age 
range, this association may be coincidental. Other explana-
tory theories include mechanical pressure on vessel walls 
associated with protracted delivery, hyperextension of the 
neck during (general) anesthesia or hemodynamic and hor-
monal changes related to pregnancy and postpartum that 
may lead to transient vulnerability of the vessel walls [10].
In one-third of patients no underlying disease or trig-
gering event was identified. Triple or quadruple vessel dis-
sections without any reason seem unlikely. The underly-
ing cause may be a yet to be defined genetic arteriopathy, 
transient (inflammatory) vulnerability of the vessel walls, 
mechanical factors such as minor trauma related to daily 
activities and sports activities, or any combination of the 
above.
There are no evidence-based guidelines on the optimal 
treatment of triple or quadruple CeAD. Our data show 
that most of these patients are managed medically. We did 
observe treatment variation in the type of medical therapy, 
with both antiplatelets and anticoagulants used in similar 
frequencies. In the CADISS trial, no difference was found 
between antiplatelets and anticoagulants in the prevention of 
stroke and death in patients with single CeAD [11].
Surprisingly, 88% of patients with triple or quadruple 
CeAD had no or only minor disability at follow-up (mRS 
0–2), and the proportion of good outcome is comparable to 
the outcome in a large cohort of patients with double and 
single CeAD (88% mRS 0–2) [3] (Online Resource Table 
II). One potential explanation may be that only 57% of triple 
or quadruple CeAD patients suffered ischemic stroke, and 
that in most patients, stroke was confined to the vascular ter-
ritory of a single artery. The proportion of ischemic stroke 
at baseline in triple or quadruple CeAD appears to be lower 
than reported in single CeAD (74–76%) [3, 5] and similar 
to double CeAD (67%) (Online Resource Table II). Perhaps 
because local symptoms are more pronounced in multiple 
dissections, the likelihood of diagnosing the condition before 
ischemic stroke has occurred is higher. Alternatively, selec-
tive publication of patients with triple or quadruple CeAD 
and a good outcome may also play a role.
Recurrences of CeAD were reported in only 3%, which 
is similar to a recent large cohort study of patients with 
double and single CeAD and comparable follow-up period 
[3] [Online Resource Table II]. In an earlier smaller study 
of 200 patients with CeAD (46 patients with double and 
9 patients with triple or quadruple CeAD) and a median 
follow-up period of 7.4 years, recurrent CeAD occurred in 
Journal of Neurology 
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8% of patients, but only in arteries that were not previously 
affected [4]. The risk of recurrence was highest in the first 
month, and after the first month the risk of recurrent dis-
section was 1% per year. According to another recent study, 
patients with late recurrent CeAD tend to be younger than 
those with recurrent CeAD within the first month (mean age 
37.5 ± 6.9 vs 43.8 ± 9.9) [12]. Based on our data, the risk 
of recurrence does not appear to be higher in patients with 
triple and quadruple CeAD. This low risk of recurrence in 
patients with triple and quadruple CeAD argues in favor of 
a transient arteriopathy rather than an underlying genetic 
arteriopathy in the majority of patients.
Our review has several limitations. First, despite our best 
efforts, we could not acquire individual patient data from 
3 out of 55 studies. Second, there is almost certainly some 
degree of publication bias, which may lead to an overesti-
mation of good clinical outcome and low recurrence rate. 
Third, recall bias may play a role in the large number of 
reported triggering events. Fourth, the absence of a reference 
group limits the interpretation of the findings. In an attempt 
to improve interpretation, we compared key findings of our 
study to available literature on double and single dissections 
from one of the largest and most well-defined CeAD mul-
ticenter cohort studies. Of course, this comparison must be 
interpreted with caution, since it is subject to data collection 
bias. Fifth, although triple and quadruple CeAD were simul-
taneously present on baseline imaging in the vast majority of 
patients in our study, we cannot be certain that they occurred 
at the same point in time. The distinction between multi-
ple and early recurrent dissections is a matter of debate and 
depends in part on the delay between symptom onset and 
diagnosis by cervical artery imaging [5, 12]. Sixth, there 
was no centralized reading of imaging and results from the 
CADISS trial have shown that diagnosis of CeAD can be 
difficult [11].
Conclusion
In conclusion, our systematic review on triple or quadruple 
dissections shows that this condition mostly affects young 
women, and that an underlying disease or triggering event 
can be identified in more than two-thirds of patients. Less 
than two-thirds of triple or quadruple CeAD patients suf-
fered ischemic stroke, and the stroke was usually confined to 
the vascular territory of a single artery. Most patients were 
managed medically and the prognosis of triple and quadru-
ple CeAD was favorable in the majority of patients, with a 
low recurrence risk.
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